Hospital pharmacy is a key component of the healthcare system and plays an essential role in ensuring continuous, safe and rational medication management during crises. Pandemics, natural disasters, armed conflicts, cyberattacks, supply-chain disruptions and medicine shortages require hospital pharmacies to operate under uncertainty and limited resources. This review aims to analyse the role of hospital pharmacy in crisis management, the main challenges and the opportunities to strengthen resilience and preparedness for future emergencies. A narrative review of scientific publications, international guidelines, professional recommendations and strategic documents addressing medicine supply, inventory management, medicine shortages, pharmaceutical care, digitalisation and medication safety in crisis settings was conducted. The analysis indicates that hospital pharmacies should be regarded as strategic centres for medication and risk management. Key resilience factors include advance planning, supplier diversification, critical-medicine lists, inventory monitoring, clear communication algorithms, staff training and the integration of pharmacists into multidisciplinary crisis teams. Resilient hospital pharmacy requires a systematic approach based on risk assessment, scenario planning, digital tools, standardised procedures and continuous improvement.
Miljković N, Polidori P, Leonardi Vinci D, Kuruc Poje D, Makridaki D, Kohl S, Süle A. Results of EAHP's 2023 shortages survey. Eur J Hosp Pharm. 2025;32(4):307–315. doi:10.1136/ejhpharm-2024-004090.
European Medicines Agency. Union list of critical medicines [Internet]. Amsterdam: European Medicines Agency (EMA). Available from: https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/medicine-shortages-availability-issues/availability-medicines-during-crises
European Medicines Agency. Medicine shortages and availability issues [Internet]. Amsterdam: EMA. Available from: https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/medicine-shortages-availability-issues
European Commission. Pharmaceutical strategy for Europe. Brussels: European Commission; 2020.
Fox ER, McLaughlin MM. ASHP guidelines on managing drug product shortages. Am J Health Syst Pharm. 2018;75(21):1742–1750. doi:10.2146/ajhp180441.
De Weerdt E, Simoens S, Casteels M, Huys I. Clinical, economic and policy implications of drug shortages in the European Union. Appl Health Econ Health Policy. 2017;15(4):441–445. doi:10.1007/s40258-016-0264-z.
Acosta A, Vanegas EP, Rovira J, Godman B, Bochenek T. Medicine shortages: gaps between countries and global perspectives. Front Pharmacol. 2019;10:763. doi:10.3389/fphar.2019.00763.
Badreldin HA, Atallah B. Global drug shortages due to COVID-19: impact on patient care and mitigation strategies. Res Social Adm Pharm. 2021;17(1):1946–1949. doi:10.1016/j.sapharm.2020.05.017.
Ivanov A, Grigorov E, Popivanov I. Digital transformation in military medicine and pharmacy - key aspects and challenges. J of IMAB. 2026;32(1):6741–6746. doi:10.5272/jimab.2026321.6741.
World Health Organization. Global patient safety action plan 2021-2030: towards eliminating avoidable harm in health care. Geneva: World Health Organization; 2021.
International Organization for Standardization. ISO 22301:2019 Security and resilience — Business continuity management systems — Requirements. Geneva: International Organization for Standardization; 2019.
International Organization for Standardization. ISO 31000:2018 Risk management — Guidelines. Geneva: International Organization for Standardization; 2018.
European Centre for Disease Prevention and Control. Health emergency preparedness for imported cases of high-consequence infectious diseases. Stockholm: ECDC; 2019.
Burnett R. Current issues facing hospital pharmacy in 2025 [Internet]. CompleteRx; 2025 Jan 20. Available from: https://www.completerx.com/blog/current-issues-facing-hospital-pharmacy-2025/
Email this article (Login required) 
